Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common Growth (3y) (2012 - 2018)
Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common Growth (3y) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 8.78% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -1.77% |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -0.98% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -65.41% |
| Dec 31, 2017 | -31.61% |
| Sep 30, 2017 | -25.21% |
| Jun 30, 2017 | 4.89% |
| Mar 31, 2017 | 5.94% |
| Dec 31, 2016 | 7.83% |
| Sep 30, 2016 | 8.80% |
| Jun 30, 2016 | 4.97% |
| Mar 31, 2016 | 2.99% |
| Dec 31, 2015 | 10.66% |
| Sep 30, 2015 | 6.59% |
| Jun 30, 2015 | 7.78% |
| Mar 31, 2015 | 18.56% |
| Dec 31, 2014 | 12.70% |
| Sep 30, 2014 | 12.96% |
| Jun 30, 2014 | 13.78% |
| Mar 31, 2014 | 12.75% |
| Dec 31, 2013 | 17.07% |
| Sep 30, 2013 | 16.49% |
| Jun 30, 2013 | 17.79% |